Asparaginase Market Size | Global Analysis and Forecast 2028
预计天冬酰胺酶市场规模将从 2021 年的 5.6401 亿美元增长至 2028 年的 15.7562 亿美元。预计 2022 年至 2028 年的复合年增长率为 16.1%。
天冬酰胺酶是一种分解天冬酰胺的酶。天冬酰胺酶被用作化疗药物,用于治疗急性淋巴细胞白血病 (ALL)、淋巴细胞淋巴瘤 (LBL) 和某些其他血癌。与正常细胞不同,ALL 细胞无法制造天冬酰胺。因此,天冬酰胺酶可阻止癌细胞分裂和生长。天冬酰胺酶来源于大肠杆菌、菊欧文氏菌、聚乙二醇化天冬酰胺酶、真菌、藻类等。
全球天冬酰胺酶市场根据类型、应用、最终用途行业和地域进行细分。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。本报告提供了对市场的见解和深入分析,重点关注市场趋势和动态等参数,以及全球领先市场参与者的竞争分析。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
天冬酰胺酶市场:
复合年增长率(2021 - 2028 年)16.1%- 2021 年市场规模
5.6401 亿美元 - 市场规模 2028 年
15.7562 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 施维雅制药有限公司
- 爵士制药公司
- BioVendor 研发
- 创意酵素
- 美达克有限公司
- 常州千红生物制药有限公司
- 联合生物技术
- 博腾生物制药
- 泰姬制药有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 大肠杆菌
- 菊欧文氏菌
- 聚乙二醇化
- 其他的
- 治疗
- 食品加工
- 其他的
- 医疗保健和食品制造
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察
医药和食品行业大幅增长推动全球天冬酰胺酶市场
制药和食品行业发展迅速,并观察到各种发展以确保食品和药品的高质量。 根据欧洲制药工业和协会联合会的数据,北美在 2021 年占全球药品销售额的 49%,在 2015 年至 2020 年期间占新上市药品销售额的 63.7%。 此外,在研发活动激增的支持下,制药行业正在以显着的速度发展,市场参与者对制药行业的投资增加进一步推动了市场的发展。
食品行业不断扩大,对食品的需求不断增加。新奇食品产品也不断增加。如今,制造商注重食品的营养量。全球油炸和烘焙食品的消费量大幅增加,对此类食品的偏好也激增。天冬酰胺酶是降低羰基源浓缩油炸和烘焙食品中糖分的主要氨基酸。
类型洞察
根据类型,全球天冬酰胺酶市场细分为大肠杆菌(E. coli)、欧文氏菌、聚乙二醇化和其他。大肠杆菌部分在 2021 年占据了更大的市场份额,预计该部分将在 2022-2028 年的预测期内在市场上实现最高的复合年增长率,这是由于对大肠杆菌衍生的天冬酰胺酶用于治疗癌症(例如 ALL 和 LBL)的需求不断增加。
大肠杆菌天冬酰胺酶衍生的天冬酰胺酶用于治疗急性淋巴细胞白血病。天冬酰胺酶大肠杆菌是一种催化 L-天冬酰胺转化为 L-天冬氨酸和氨的酶。它有助于产生细胞代谢所需的草酰乙酸。大肠杆菌天冬酰胺酶具有抗肿瘤特性,可用于治疗白血病。因此,用于癌症治疗(尤其是儿科患者)的天冬酰胺酶大肠杆菌的需求正在推动市场增长。
应用程序洞察
根据应用,全球天冬酰胺酶市场分为治疗、食品加工和其他。治疗领域在 2021 年占据了更大的市场份额,由于其用于治疗淋巴增生性疾病和淋巴瘤,预计该领域将实现最高的复合年增长率。该领域进一步细分为急性淋巴细胞白血病、淋巴细胞淋巴瘤和其他。
急性淋巴细胞白血病是一种血癌和骨髓癌,如果不治疗会致命。根据卫生指标与评估研究所的数据,2019 年全球报告了约 153,000 例急性淋巴细胞白血病新病例和 47,600 例急性淋巴细胞白血病死亡病例。因此,全球急性淋巴细胞白血病病例的增加正在推动全球天冬酰胺酶市场的增长。
天冬酰胺酶市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 5.6401亿美元 |
2028 年市场规模 | 15.7562亿美元 |
全球复合年增长率(2021 - 2028) | 16.1% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
最终用途行业洞察
根据最终用途,全球天冬酰胺酶市场细分为医疗保健和食品制造。医疗保健部门在 2021 年占据了更大的市场份额。此外,预计同一部门将在 2022 年至 2028 年期间实现最高复合年增长率。该部门增长的驱动因素是急性淋巴细胞白血病、淋巴母细胞淋巴瘤的增加以及不断增长的研究活动。
市场上见证的无机增长战略是并购、伙伴关系和合作。这些活动为业务的扩张和市场参与者的客户群铺平了道路。以下列出了一些最近的关键市场发展:
- 2021年5月,Jazz Pharmaceuticals收购了GW制药公司,以增强其研发能力。此次收购还将帮助该公司开发和商业化基于大麻素的处方药。
- 2021 年 4 月,施维雅完成了对 Agios Pharmaceuticals 价值 20 多亿美元的专利使用费的收购,包括商业、临床和研究阶段的肿瘤学产品组合。此次收购增强了施维雅在美国恶性血液学市场的商业影响力,并为实体肿瘤领域的长期增长提供了潜力。
- 2018 年 8 月,Medac GmBH 与 FarmaMondo SA 合作,通过托管访问计划向俄罗斯、格鲁吉亚、阿塞拜疆、吉尔吉斯斯坦、乌兹别克斯坦和摩尔多瓦的目标医疗保健提供商独家分销 Spectrila。FarmaMondo 将管理急性淋巴细胞白血病患者对 Spectrila 的访问。
全球天冬酰胺酶市场的一些主要参与者包括 Servier Pharmaceuticals LLC、BioVendor R&D、Creative Enzymes、medac GmbH、常州千宏生物制药有限公司、United Biotech、Porton Biopharma、Taj Pharmaceuticals Limited 和 Jazz Pharmaceuticals plc。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Escherichia Coli segment held the largest share of the market in the global asparaginase market contributing a market share of 49.78% in 2021.
The Asia Pacific is expected to be the fastest-growing region in the asparaginase market over the forecast period due to increasing prevalence of acute lymphoblastic leukemia, increasing research activities in cancer, and increasing innovative products for treatment of hematological cancers by the market players in the region.
The asparaginase market is estimated to be valued at US$ 564.01 million in 2021.
The asparaginase market is expected to be valued at US$ 1,575.62 million in 2028.
The CAGR value of the asparaginase market during the forecasted period of 2022-2028 is 16.1%
The asparaginase market majorly consists of the players, such as Servier Pharmaceuticals LLC, Jazz Pharmaceuticals plc, BioVendor R&D, Creative Enzymes, medac GmbH, Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, and Taj Pharmaceuticals Limited and among others.
The factors that are driving the growth of the asparaginase market are rising incidences of leukemia and increasing usage applications and significant growth of the pharmaceutical and food industry are the major factors contributing to the growth of the asparaginase industry.
Asparaginase is an enzyme that breaks down asparagine. Asparaginase is used as a chemotherapy drug to treat acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), and certain other blood cancers. Unlike normal cells, ALL cells are unable to make their own asparagine. Therefore, asparaginase stops the cancer cells from dividing and growing. Asparaginase are derived from Escherichia coli, Erwinia chrysanthemi, pegylated asparaginase, fungi, algae and others.
The List of Companies - Asparaginase Market
- Servier Pharmaceuticals LLC
- Jazz Pharmaceuticals plc
- BioVendor R&D
- Creative Enzymes
- medac GmbH
- Changzhou Qianhong Bio-pharma Co Ltd
- United Biotech
- Porton Biopharma
- Taj Pharmaceuticals Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.